Skip to main content

Day: April 6, 2020

Suominen and Ahlstrom-Munksjö strengthen their co-operation

Suominen Corporation’s press release on April 6, 2020 at 9:00 a.m. (EEST)Suominen and Ahlstrom-Munksjö have signed a multi-year commercial agreement that renews and strengthens the existing co-operation at the Ställdalen plant in Sweden. The agreement secures supplies from Ställdalen to Suominen’s customers for several years and will also considerably improve the companies’ joint service to the customers.Ställdalen manufactures Suominen’s HYDRASPUN® product family mainly for the European market. HYDRASPUN® products are 100% biodegradable and produced from renewable materials. The products are considered category leader in the Moist Toilet Tissue segment (MTT). Suominen produces the same products at its Windsor Locks and Bethune plants in the US and the signed commercial agreement further improves Suominen’s ability to...

Continue reading

Suominen ja Ahlstrom-Munksjö vahvistavat yhteistyötään

Suominen Oyj:n lehdistötiedote 6.4.2020 klo 9.00Suominen ja Ahlstrom-Munksjö ovat allekirjoittaneet monivuotisen sopimuksen, joka uudistaa ja vahvistaa yhtiöiden kaupallista yhteistyötä Ställdalenin tehtaalla Ruotsissa. Sopimus varmistaa tuotteiden saatavuuden Ställdalenista Suomisen asiakkaille useaksi vuodeksi ja parantaa huomattavasti yhtiöiden yhteistä palvelua asiakkaille.  Ställdalenissa valmistetaan Suomisen HYDRASPUN® tuoteperhettä pääasiassa Euroopan markkinoille. HYDRASPUN®-tuotteet ovat 100 %:sti hajoavia ja ne valmistetaan uusiutuvista materiaaleista. Tuotteita pidetään luokkansa parhaina kosteiden wc-papereiden segmentissä. Suominen tekee samoja tuotteita Windsor Locksin ja Bethunen tehtaillaan Yhdysvalloissa, ja allekirjoitettu sopimus vahvistaa Suomisen kykyä palvella asiakkaitaan ympäri maailmaa. Sopimuksen myötä asiakkailla...

Continue reading

Nilörngruppen AB: withdraws dividend proposal and reschedules the interim report for the first quarter

The Board of Directors of Nilörngruppen has decided to withdraw the previously communicated proposal to the Annual General Meeting for a dividend of SEK 2.50/share (MSEK 28.5). The decision has been made in light of the prevailing very uncertain world environment, because of the outbreak of COVID-19 and its effects on the outside world and markets, and the risk of impact on Nilörngruppen’s operations and earnings.The Board of Directors has also decided to reschedule publication of the quarterly report (Q1) and will publish it on Tuesday 7 April at 8:00 a.m. Rescheduling the report will allow management to prioritize business-critical activities, while at the same time providing current financial information to the shareholders.The Annual General Meeting is expected to be held ass previously announce on 14 May at 5:00 p.m. at Nilörngruppen’s...

Continue reading

Nilörngruppen AB: drar tillbaka utdelningsförslaget och tidigarelägger delårsrapporten för första kvartalet

Styrelsen för Nilörngruppen har beslutat att dra tillbaka tidigare kommunicerat förslag till årsstämman om en utdelning om 2,50 kr/aktie (28,5 Mkr). Beslutet har fattats mot bakgrund av rådande mycket osäkra omvärldsklimat, med anledning av utbrottet av Covid-19 och dess effekter på omvärld och marknader samt risken för finansiell påverkan på Nilörngruppens verksamhet och resultat.Styrelsen har vidare beslutat att tidigarelägga kvartalsrapporten (Q1) och publicerar den tisdagen 7 april klockan 08,00. Genom att tidigarelägga rapporten kan ledningen prioritera verksamhetskritiska aktiviteter samtidigt som aktieägarna erhåller aktuell finansiell information.Årsstämman beräknas hållas som tidigare aviserats tisdagen den 14 maj 2020 kl. 17.00 på Nilörngruppens huvudkontor i Borås. Det kommer inte bjudas på någon mat detta år på grund av Covid-19...

Continue reading

Delta Drone s’implique dans la lutte contre la pandémie de Covid-19

Delta Drone s’implique dans la luttecontre la pandémie de Covid-19Dardilly et Tel-Aviv, 6 avril 2020Delta Drone a été invité, en qualité d’acteur de premier plan du secteur des drones civils et au regard de son portefeuille de solutions professionnelles, à participer pendant 2 jours, les 6 et 7 avril, à la première conférence internationale dématérialisée consacrée aux innovations technologiques professionnelles permettant de combattre efficacement la pandémie de Covid-19 :Covid-19 Innovation Conference Worldwide Online Investment EventCette conférence dématérialisée, organisée par le département Life Sciences de la banque Cukierman & Co va réunir, via un système multimédia sophistiqué permettant des présentations en groupe et des entretiens en one-to-one, tous les acteurs concernés par la problématique : groupes pharmaceutiques,...

Continue reading

BUREAU VERITAS: Cancellation of the dividend for the 2019 financial year

Press releaseNeuilly-sur-Seine, France – April 6, 2020Cancellation of the dividend for the 2019 financial yearIn the current context of the worsening global health crisis, Bureau Veritas continues to take every necessary action to protect the health of its employees and, where possible, of its clients, suppliers, and subcontractors. The Group’s businesses around the world have activated their business continuity plans and have implemented remote working wherever possible, in strict compliance with decisions taken by local governments and World Health Organization recommendations.  In this context and so as to retain its ability to bounce back rapidly after the crisis, Bureau Veritas has chosen to take up various Government schemes such as temporary layoffs in France, and the deferral of certain employment contributions and tax payments.In...

Continue reading

BUREAU VERITAS : Annulation de la proposition de dividende au titre de l’exercice 2019

Communiqué de presseNeuilly-sur-Seine, France – 6 avril 2020Annulation de la proposition de dividende au titre de l’exercice 2019Dans le contexte actuel d’aggravation de la crise sanitaire mondiale, Bureau Veritas continue de tout mettre tout en œuvre pour protéger la santé de ses collaborateurs, ainsi que, dans la mesure du possible, celle de ses clients, fournisseurs et sous-traitants. Le Groupe a adopté des plans de continuité d’activité à travers le monde et a activé le travail à distance quand cela est possible, dans le strict respect des décisions prises par les gouvernements locaux et des directives de l’Organisation mondiale de la Santé. Dans ce contexte, et afin de préserver sa faculté d’un rebond rapide après la crise, Bureau Veritas a choisi d’avoir notamment recours aux dispositifs de chômage partiel en France, ainsi qu’à...

Continue reading

Addex Therapeutics to Report 2019 Full Year Audited Results on April 8, 2020

Geneva, Switzerland, April 6, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, will discuss its full year 2019 financial results, provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and the media on Wednesday, April 8, 2020 at 16:00 CEST (15:00 BST/10:00 ET).Title:                    Addex Full Year 2019 Financial Results Conference CallDate:                   April 8, 2020Time:                  16:00 CEST (15:00 BST/10:00 ET)Joining the Conference Call:1: In the 10 minutes prior to the call start time, call the appropriate participant dial-in number.   Dial-In Numbers:Switzerland                       +41 44 580 65 22UK                                     +44 20...

Continue reading

ObsEva SA Announces New Interim Chief Financial Officer

 Geneva, Switzerland and Boston, MA – April 6, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health today announced the nomination of Fabien de Ladonchamps, Vice President Corporate Affairs & Finance, as interim Chief Financial Officer and member of the Executive Committee, following the resignation of Tim Adams, effective close of business April 10, 2020. Tim Adams has served as CFO of ObsEva since January 2017 and is departing the Company to pursue a new opportunity. “On behalf of the Board of Directors and Executive team, I would like to thank Tim for his contributions to the Company and leadership during his tenure at ObsEva.  We would also like to thank Fabien for assuming this extended responsibility and his willingness...

Continue reading

KALLELSE TILL ÅRSSTÄMMA I WESTPAY AB

Westpay AB håller årsstämma tisdagen den 5 maj 2020 klockan 15.00 i bolagets lokaler på Kanalvägen 14, 194 61 i Upplands Väsby. Registreringen börjar klockan 14.30.RÄTT ATT DELTA OCH ANMÄLAN TILL BOLAGETDen som önskar delta i stämman skadels      vara införd som aktieägare i den av Euroclear Sweden AB förda aktieboken tisdagen den 28 april 2020.dels      anmäla sin avsikt att delta till bolaget senast kl. 15.00 tisdagen den 28 april 2020.Anmälan om deltagande kan ske skriftligen till bolaget på adress Westpay AB, Kanalvägen 14, 194 61 Upplands Väsby eller per e-post till lars.levin@westpay.se. Vid anmälan vänligen uppge namn eller firma, personnummer eller organisationsnummer, adress och telefonnummer dagtid. För anmälan av biträden gäller anmälningsförfarande enligt ovan.FÖRVALTARREGISTRERADE AKTIERDen som låtit förvaltarregistrera sina...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.